Therefore, this study will explore the mechanism of CPNE3/RACK1 complex activation of the c‐MET signalling pathway to identify new strategies targeting the c‐MET signalling pathway in the clinical treatment of NSCLC. The gene discussed is RACK1; the disease is non-small cell lung carcinoma.